Russia Prepares $10 COVID-19 Vaccine For International Launch

Aims To Compete With Pfizer On Efficacy, Undercut On Price

Sputnik
Russia has just announced a second interim readout, edging its efficacy claims to over 95%. • Source: RDIF

More from Business

More from Scrip